These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20737520)

  • 21. Interactive effects of citalopram and serotonin transporter genotype on neural correlates of response inhibition and attentional orienting.
    Fischer AG; Endrass T; Goebel I; Reuter M; Montag C; Kubisch C; Ullsperger M
    Neuroimage; 2015 Aug; 116():59-67. PubMed ID: 25957993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute citalopram administration produces correlated increases in plasma and salivary cortisol.
    Bhagwagar Z; Hafizi S; Cowen PJ
    Psychopharmacology (Berl); 2002 Aug; 163(1):118-20. PubMed ID: 12185409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition.
    Ashina S; Bendtsen L; Jensen R
    Pain; 2004 Mar; 108(1-2):108-14. PubMed ID: 15109513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escitalopram effects on insula and amygdala BOLD activation during emotional processing.
    Arce E; Simmons AN; Lovero KL; Stein MB; Paulus MP
    Psychopharmacology (Berl); 2008 Mar; 196(4):661-72. PubMed ID: 18058090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
    Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
    Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans.
    Skandali N; Rowe JB; Voon V; Deakin JB; Cardinal RN; Cormack F; Passamonti L; Bevan-Jones WR; Regenthal R; Chamberlain SR; Robbins TW; Sahakian BJ
    Neuropsychopharmacology; 2018 Dec; 43(13):2645-2651. PubMed ID: 30305705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
    Auerbach SB; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
    Kellner M; Muhtz C; Demiralay C; Husemann J; Koelsch W; Yassouridis A; Wiedemann K
    J Psychiatr Res; 2009 Mar; 43(6):642-8. PubMed ID: 18930474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging.
    Sekar S; Verhoye M; Van Audekerke J; Vanhoutte G; Lowe AS; Blamire AM; Steckler T; Van der Linden A; Shoaib M
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):521-31. PubMed ID: 21103865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans.
    Kemp AH; Gray MA; Silberstein RB; Armstrong SM; Nathan PJ
    Neuroimage; 2004 Jul; 22(3):1084-96. PubMed ID: 15219580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study.
    Muraki I; Inoue T; Hashimoto S; Izumi T; Koyama T
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):568-74. PubMed ID: 18950377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
    Nguyen HT; Guiard BP; Bacq A; David DJ; David I; Quesseveur G; Gautron S; Sanchez C; Gardier AM
    Br J Pharmacol; 2013 Jan; 168(1):103-16. PubMed ID: 22233336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].
    Muraki I
    Hokkaido Igaku Zasshi; 2001 Mar; 76(2):57-70. PubMed ID: 11344903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline.
    Guille V; Croft RJ; O'Neill BV; Illic S; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2008 Apr; 23(3):231-41. PubMed ID: 18196604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning.
    Brown HD; Amodeo DA; Sweeney JA; Ragozzino ME
    J Psychopharmacol; 2012 Nov; 26(11):1443-55. PubMed ID: 22219222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval.
    Reed MB; Vanicek T; Seiger R; Klöbl M; Spurny B; Handschuh P; Ritter V; Unterholzner J; Godbersen GM; Gryglewski G; Kraus C; Winkler D; Hahn A; Lanzenberger R
    Neuroimage; 2021 Aug; 236():118039. PubMed ID: 33852940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and impact of Lsamp neural adhesion molecule in the serotonergic neurotransmission system.
    Bregin A; Kaare M; Jagomäe T; Karis K; Singh K; Laugus K; Innos J; Leidmaa E; Heinla I; Visnapuu T; Oja EM; Kõiv K; Lilleväli K; Harro J; Philips MA; Vasar E
    Pharmacol Biochem Behav; 2020 Nov; 198():173017. PubMed ID: 32828972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.